Advanced Wound Care Market

Advanced Wound Care Market by Product Type (Dressings [Foam Dressings, Hydrocolloid Dressings, Collagen Dressings, Silver Dressings, Film Dressings, and Others], Therapy Devices [Negative Pressure Wound Therapy Devices, Hyperbaric Oxygen Therapy Devices, Debridement Devices, and Others], Grafts & Matrices), Wound Type (Surgical & Traumatic Wounds, Diabetic Foot Ulcers, Burns, and Others), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World) is expected to advance at a respectable CAGR forecast till 2032 owing to the rising prevalence of chronic and acute wounds and the increase in surgical procedures worldwide

The advanced wound care market was valued at USD 9.45 billion in 2023, growing at a CAGR of 10.51% during the forecast period from 2025 to 2032, to reach USD 16.97 billion by 2032. The advanced wound care market is expanding rapidly due to the collective impact of rising chronic and acute wound prevalence such as diabetic ulcers and pressure sores, increasing surgical procedures, and the growing product launches and approvals by key market players is expected to significantly drive the demand for advanced wound care from 2025 to 2032.

Advanced Wound Care Market Dynamics:

According to the latest data provided by Diabetes Feet Australia (DFA) (2022), in Australia, 300,000 individuals are at risk of developing diabetic foot disease (DFD) per 100,000 population, with 50,000 already living with the condition. Of these, 12,500 people have undergone diabetes-related amputations, and 1,000 are currently hospitalized due to DFD. Each year, 12 new diabetes-related amputations are performed per 100,000 population.

Additionally, according to the recent data and stats provided by IDF Atlas Report (2022), in African countries, the rates of diabetic foot ulcers (DFU) range from 10.0% to 30.0%, while the prevalence of lower limb amputations (LLA) varies between 3.0% and 35.0%.

Diabetic foot ulcers are chronic wounds that often require specialized treatment and advanced wound care solutions. As the prevalence of these ulcers rises, there is a growing demand for products that can effectively manage and close these wounds. In addition to this, diabetic-related amputations often require wound closure devices for both the initial wound and ongoing care. Advanced wound closure products help manage surgical sites and promote healing, reducing the likelihood of further complications and repeat surgeries. 

As per recent data from the World Bank Group, in 2022, Germany performed approximately 19,124 surgical procedures per 100,000 population. Finland recorded 15,870 surgical procedures per 100,000 population in the same year. Also in Hong Kong, China performed 1,735 surgical procedures per 100,000 population in 2023. As the number of surgical procedures rises, whether due to a growing population, advancements in medical technology, or more surgeries being performed for various conditions, the need for advanced wound care devices correspondingly increases.

Moreover, companies are amplifying their production of advanced wound care and securing regulatory approvals, thereby strategically expanding their market presence and driving further growth. For instance, in June 2023, Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) received approval from the Central Drugs Standard Control Organization (CDSCO) for its advanced wound care product called Cholederm. It is used for faster healing of various skin wounds, including burns and diabetic wounds. Cholederm is expected to reduce treatment costs and make advanced wound care more affordable.

Therefore, all the factors stated above collectively will drive the overall advanced wound care market during the forecast period from 2025 to 2032.

However, the rising preference for minimally invasive surgeries and the risk of infection among others may limit their end-user base, thus acting as key constraints limiting the growth of the advanced wound care market.

Advanced Wound Care Market Segment Analysis:

Advanced Wound Care Market by Product Type (Dressings [Foam Dressings, Hydrocolloid Dressings, Collagen Dressings, Silver Dressings, Film Dressings, and Others], Therapy Devices [Negative Pressure Wound Therapy Devices, Hyperbaric Oxygen Therapy Devices, Debridement Devices, and Others], Grafts & Matrices), Wound Type (Surgical & Traumatic Wounds, Diabetic Foot Ulcers, Burns, and Others), End-User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

In the product type segment of advanced wound care, the dressing category is expected to have a significant revenue share in the year 2023. This is due to the availability of a wide variety of advanced dressings such as foam dressings, silver dressings, and film dressings, among others. Also, foam dressing among all the dressing categories is projected to have a lucrative growth during the forecasted period as these are usually made of polyurethane foam making it hydrophilic. The rate of absorbency differs with their composite and thickness. However, some provide an absorption capacity of up to 7 days. The advantages associated with foam dressing such as moisture wound healing, non-adherent nature, and bacterial barrier are further increasing their demand.

Additionally, a new development in the dressing product lines and new product launches are bolstering the category growth of the advanced wound care market. For instance, in October 2023, DuPont introduced a new soft skin adhesive for wound care dressings, known as DuPont Liveo MG 7-9960. This innovative adhesive is designed to be non-sensitizing, non-irritating, and non-cytotoxic, making it ideal for protecting sensitive and fragile skin. The new higher-adhesion, low-cyclic silicone soft skin adhesive provides enhanced performance and comfort for wound care applications.

Therefore, owing to the above-mentioned factors, the demand for the dressing category upsurges, owing to which the category is expected to witness considerable growth eventually contributing to the overall growth of the advanced wound care market during the forecast period from 2025 to 2032.

North America is expected to dominate the overall advanced wound care market:

Among all the regions, North America is expected to dominate the advanced wound care market in the year 2023 and is expected to do the same during the forecast period from 2025 to 2032. This is driven by the increasing instances of traumatic brain injury and surgical procedure, the rising cases of diabetes leading to amputation, and advancement in advanced wound care, regulatory support, and the introduction of innovative products by the market key players are anticipated to significantly propel market growth for advanced wound care from 2025 to 2032.

As per the American Society for Biochemistry and Molecular Biology in the year 2021, in the United States, a brain injury occurs every nine seconds, resulting in more than 3.5 million incidents each year. The above-mentioned source further stated that about 2.8 million people suffer from traumatic brain injury each year in the United States from which 2,80,000 people result in hospitalizations. Also, as per the recent data provided by the World Bank Group, in 2021, approximately 6,928 surgical procedures were performed per 100,000 population in Canada. Advanced wound care is crucial in managing traumatic brain injuries and supporting recovery. These include specialized dressings and bioengineered materials that promote healing, reduce infection risk, and support tissue regeneration. In the context of brain injuries, they can aid in the care of surgical wounds, manage complications, and enhance overall recovery by providing a conducive environment for healing.

As per the recent data provided by the Centre for Disease Control and Prevention (2025), in 2021, 38.4 million people of all ages or 11.6% of the U.S. population had diabetes. Additionally, as per the same source, 80% of Lower-limb amputations (LLAs) are a result of complications from diabetes. Advanced wound care is essential for managing diabetes-related complications and preventing lower-limb amputations. It uses specialized dressings, antimicrobial treatments, and debridement to promote healing and reduce infection risks. Effective wound care helps prevent minor injuries from worsening, thus lowering the likelihood of severe complications and amputations.

Additionally, the increasing number of product development activities in the region is further going to accelerate the growth of the advanced wound care market. For instance, in April 2023, 3M Health Care's groundbreaking 3M™ Veraflo™ Therapy, which includes both the 3M™ Veraflo™ Cleanse Choice Complete™ Dressing and the 3M™ V.A.C. Veraflo Cleanse Choice™ Dressing, was the first to receive FDA clearance for its hydromechanical removal of infectious materials, non-viable tissue, and wound debris. This innovative therapy reduces the need for surgical debridements, supports the formation of granulation tissue, and creates an optimal environment for wound healing.

In addition to this In April 2025, Smith & Nephew Plc introduced the Renasys Edge Negative Pressure Wound Therapy (NPWT) System in the US, marking a significant advancement in home-based treatment for chronic wounds. NPWT devices are wound care systems that apply sub-atmospheric pressure to the wound area continuously or intermittently.

Therefore, the interplay of all the aforementioned factors above would provide a conducive growth environment for the North America region in the advanced wound care market.

Advanced Wound Care Market key players:

Some of the key market players operating in the advanced wound care market include Smith & Nephew Plc, Mölnlycke Health Care AB, ConvaTec Group, 3M, Accel-Heal, Zimmer Biomet, B. Braun Melsungen AG, Cardinal Health Inc., DermaRite Industries LLC, Lohmann & Rauscher, Hollister Incorporated, Welcare Industries S.p.A, Mil Laboratories, Coloplast Group, HARTMANN USA, Inc., and others.

Recent Developmental Activities in the Advanced Wound Care Market:

• In August 2025, Stramsen Biotech submitted a Pre-IND meeting request to the FDA for SBX1977, its wound care medicine, along with a full pre-clinical data package in preparation for clinical trials.
• In May 2022, Advanced Medical Solutions Group plc, a world leader in tissue-healing technologies, announced that it received FDA 510(k) approval for LiquiBand® XL. This new device, designed to close longer wounds, included a surgical mesh for wound closure and LiquiBand® glue to strengthen the closure and prevent infection.
• In August 2023, Medela, Inc., announced that it introduced a new innovative sterile dressing within its negative pressure wound therapy (NPWT) portfolio. The Invia® Integrated Dressing was indicated for all wound types, including closed surgical incisions, and could be used in both hospital and home settings for up to seven days
• In January 2021, Integra LifeSciences completed the acquisition of Acell Inc. Together with ACell Inc. the company is looking forward to continuing to advance wound care innovation.

Key Takeaways from the Advanced Wound Care Market Report Study

• Market size analysis for current advanced wound care market size (2023), and market forecast for 6 years (2025 to 2032)
• Top key product/services developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years
• Key companies dominating the advanced wound care market
• Various opportunities available for the other competitors in the advanced wound care market space
• What are the top-performing segments in 2023? How these segments will perform in 2032?
• Which are the top-performing regions and countries in the current advanced wound care market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for advanced wound care market growth in the coming future?

Target audience who can be benefited from this Advanced Wound Care Market Report Study

• Advanced wound care product providers
• Research organizations and consulting companies
• Advanced wound care-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and traders dealing in advanced wound care 
• Various end-users who want to know more about the advanced wound care market and the latest developments in the advanced wound care market